Old Web
English
Sign In
Acemap
>
authorDetail
>
John Palmer
John Palmer
Eli Lilly and Company
Agonist
Purine
Cannabinoid receptor type 2
In vivo
Purine metabolism
2
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain.
2013
Journal of Medicinal Chemistry
Sean P. Hollinshead
Michael Wade Tidwell
John Palmer
Rossella Guidetti
Adam J. Sanderson
Michael P. Johnson
Mark Chambers
J.L. Oskins
Robert E. Stratford
Peter Charles Astles
Show All
Source
Cite
Save
Citations (24)
Discovery and optimization of novel purines as potent and selective CB2 agonists
2012
Bioorganic & Medicinal Chemistry Letters
Sean P. Hollinshead
Peter Charles Astles
Mark Chambers
Michael P. Johnson
John Palmer
Michael Wade Tidwell
Show All
Source
Cite
Save
Citations (15)
1